Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
Dutta P, Reddy KS, Rai A, Madugundu AK, Solanki HS, Bhansali A, Radotra BD, Kumar N, Collier D, Iacovazzo D, Gupta P, Raja R, Gowda H, Pandey A, Devgun JS, Korbonits M.
Dutta P, et al. Among authors: bhansali a.
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3539-3544. doi: 10.1210/jc.2019-00432.
J Clin Endocrinol Metab. 2019.
PMID: 31125088
Free PMC article.